Cargando…
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652741/ https://www.ncbi.nlm.nih.gov/pubmed/32474767 http://dx.doi.org/10.1007/s40618-020-01258-w |
_version_ | 1783607754183671808 |
---|---|
author | Perros, P. Žarković, M. P. Panagiotou, G. C. Azzolini, C. Ayvaz, G. Baldeschi, L. Bartalena, L. Boschi, A. M. Nardi, M. Brix, T. H. Covelli, D. Daumerie, C. Eckstein, A. K. Fichter, N. Ćirić, S. Hegedüs, L. Kahaly, G. J. Konuk, O. Lareida, J. J. Okosieme, O. E. Leo, M. Mathiopoulou, L. Clarke, L. Menconi, F. Morris, D. S. Orgiazzi, J. Pitz, S. Salvi, M. Muller, I. Knežević, M. Wiersinga, W. M. Currò, N. Dayan, C. M. Marcocci, C. Marinò, M. Möller, L. Pearce, S. H. Törüner, F. Bernard, M. |
author_facet | Perros, P. Žarković, M. P. Panagiotou, G. C. Azzolini, C. Ayvaz, G. Baldeschi, L. Bartalena, L. Boschi, A. M. Nardi, M. Brix, T. H. Covelli, D. Daumerie, C. Eckstein, A. K. Fichter, N. Ćirić, S. Hegedüs, L. Kahaly, G. J. Konuk, O. Lareida, J. J. Okosieme, O. E. Leo, M. Mathiopoulou, L. Clarke, L. Menconi, F. Morris, D. S. Orgiazzi, J. Pitz, S. Salvi, M. Muller, I. Knežević, M. Wiersinga, W. M. Currò, N. Dayan, C. M. Marcocci, C. Marinò, M. Möller, L. Pearce, S. H. Törüner, F. Bernard, M. |
author_sort | Perros, P. |
collection | PubMed |
description | PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group on Graves’ Orbitopathy (EUGOGO) tertiary centres. New patients presenting over a 4 month period with a diagnosis of Graves’ orbitopathy were included. Patient demographics were collected and a clinical examination was performed based on a previously published protocol. Patients were categorized as having asymmetric, symmetric, and unilateral Graves’ orbitopathy. The distribution of clinical characteristics among the three groups was documented. RESULTS: The asymmetric group (n = 83), was older than the symmetric (n = 157) group [mean age 50.9 years (SD 13.9) vs 45.8 (SD 13.5), p = 0.019], had a lower female to male ratio than the symmetric and unilateral (n = 29) groups (1.6 vs 5.0 vs 8.7, p < 0.001), had more active disease than the symmetric and unilateral groups [mean linical Activity Score 3.0 (SD 1.6) vs 1.7 (SD 1.7), p < 0.001 vs 1.3 (SD 1.4), p < 0.001] and significantly more severe disease than the symmetric and unilateral groups, as measured by the Total Eye Score [mean 8.8 (SD 6.6) vs 5.3 (SD 4.4), p < 0.001, vs 2.7 (SD 2.1), p < 0.001]. CONCLUSION: Older age, lower female to male ratio, more severe, and more active disease cluster around asymmetric Graves’ orbitopathy. Asymmetry appears to be a marker of more severe and more active disease than other presentations. This simple clinical parameter present at first presentation to tertiary centres may be valuable to clinicians who manage such patients. |
format | Online Article Text |
id | pubmed-7652741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-76527412020-11-12 Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study Perros, P. Žarković, M. P. Panagiotou, G. C. Azzolini, C. Ayvaz, G. Baldeschi, L. Bartalena, L. Boschi, A. M. Nardi, M. Brix, T. H. Covelli, D. Daumerie, C. Eckstein, A. K. Fichter, N. Ćirić, S. Hegedüs, L. Kahaly, G. J. Konuk, O. Lareida, J. J. Okosieme, O. E. Leo, M. Mathiopoulou, L. Clarke, L. Menconi, F. Morris, D. S. Orgiazzi, J. Pitz, S. Salvi, M. Muller, I. Knežević, M. Wiersinga, W. M. Currò, N. Dayan, C. M. Marcocci, C. Marinò, M. Möller, L. Pearce, S. H. Törüner, F. Bernard, M. J Endocrinol Invest Original Article PURPOSE: Patients with Graves’ orbitopathy can present with asymmetric disease. The aim of this study was to identify clinical characteristics that distinguish asymmetric from unilateral and symmetric Graves’ orbitopathy. METHODS: This was a multi-centre study of new referrals to 13 European Group on Graves’ Orbitopathy (EUGOGO) tertiary centres. New patients presenting over a 4 month period with a diagnosis of Graves’ orbitopathy were included. Patient demographics were collected and a clinical examination was performed based on a previously published protocol. Patients were categorized as having asymmetric, symmetric, and unilateral Graves’ orbitopathy. The distribution of clinical characteristics among the three groups was documented. RESULTS: The asymmetric group (n = 83), was older than the symmetric (n = 157) group [mean age 50.9 years (SD 13.9) vs 45.8 (SD 13.5), p = 0.019], had a lower female to male ratio than the symmetric and unilateral (n = 29) groups (1.6 vs 5.0 vs 8.7, p < 0.001), had more active disease than the symmetric and unilateral groups [mean linical Activity Score 3.0 (SD 1.6) vs 1.7 (SD 1.7), p < 0.001 vs 1.3 (SD 1.4), p < 0.001] and significantly more severe disease than the symmetric and unilateral groups, as measured by the Total Eye Score [mean 8.8 (SD 6.6) vs 5.3 (SD 4.4), p < 0.001, vs 2.7 (SD 2.1), p < 0.001]. CONCLUSION: Older age, lower female to male ratio, more severe, and more active disease cluster around asymmetric Graves’ orbitopathy. Asymmetry appears to be a marker of more severe and more active disease than other presentations. This simple clinical parameter present at first presentation to tertiary centres may be valuable to clinicians who manage such patients. Springer International Publishing 2020-05-30 2020 /pmc/articles/PMC7652741/ /pubmed/32474767 http://dx.doi.org/10.1007/s40618-020-01258-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Perros, P. Žarković, M. P. Panagiotou, G. C. Azzolini, C. Ayvaz, G. Baldeschi, L. Bartalena, L. Boschi, A. M. Nardi, M. Brix, T. H. Covelli, D. Daumerie, C. Eckstein, A. K. Fichter, N. Ćirić, S. Hegedüs, L. Kahaly, G. J. Konuk, O. Lareida, J. J. Okosieme, O. E. Leo, M. Mathiopoulou, L. Clarke, L. Menconi, F. Morris, D. S. Orgiazzi, J. Pitz, S. Salvi, M. Muller, I. Knežević, M. Wiersinga, W. M. Currò, N. Dayan, C. M. Marcocci, C. Marinò, M. Möller, L. Pearce, S. H. Törüner, F. Bernard, M. Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
title | Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
title_full | Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
title_fullStr | Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
title_full_unstemmed | Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
title_short | Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
title_sort | asymmetry indicates more severe and active disease in graves’ orbitopathy: results from a prospective cross-sectional multicentre study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652741/ https://www.ncbi.nlm.nih.gov/pubmed/32474767 http://dx.doi.org/10.1007/s40618-020-01258-w |
work_keys_str_mv | AT perrosp asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT zarkovicmp asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT panagiotougc asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT azzolinic asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT ayvazg asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT baldeschil asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT bartalenal asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT boschiam asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT nardim asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT brixth asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT covellid asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT daumeriec asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT ecksteinak asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT fichtern asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT cirics asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT hegedusl asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT kahalygj asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT konuko asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT lareidajj asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT okosiemeoe asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT leom asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT mathiopouloul asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT clarkel asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT menconif asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT morrisds asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT orgiazzij asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT pitzs asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT salvim asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT mulleri asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT knezevicm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT wiersingawm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT curron asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT dayancm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT marcoccic asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT marinom asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT mollerl asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT pearcesh asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT torunerf asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT bernardm asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy AT asymmetryindicatesmoresevereandactivediseaseingravesorbitopathyresultsfromaprospectivecrosssectionalmulticentrestudy |